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Cavernous sinus syndrome caused by a metastasis of a
thymic carcinoid tumor












sinus syndrome was treated successfully. This is the first case report
of a thymic carcinoid to metastasize to the cavernous sinus. Ahu Hayretdag
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Zusammenfassung
Neuroendokrine Tumoren des Thymus, auch als Thymuscarcinoide be-
kannt, gehören zu den seltenen Tumoren des vorderen Mediastinums
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und haben der Regel eine ungünstige Prognose. Im nachfolgenden Fall
wird dargestellt, dass auch ein Thymuscarcinoid, welches zu eimen
CavernösenSinusSyndromführte,erfolgreichbehandeltwerdenkann. 2 Department of Chest
Disease,FacultyofMedicine,




malignant and aggressive [1]. They have been shown to
arise from neuroendocrine cells that are normally found
in the thymus.
Thymic carcinoid tumors make up only 4% of all anterior
mediastinaltumorsandusuallyoccurinpatientsbetween
the ages of 40 and 70. These tumors are three times
more likely to affect men than women [2]. 65% of all
casesarediscoveredincidentallyduringaroutinephysical
examination.
These tumors tend to invade adjacent structures, recur
locallyorcausehematogenousmetastasesinotherareas
of the body. In central the nervous system, metastases
of the thymic carcinoid may lead to a cavernous sinus
syndrome.
Treatment of a patient with this tumor calls for prompt




ing of pain in the anterior chest wall and shortness of
breath. The physical examination detected minimal hep-
atomegaly.Achestx-rayshowedanodulardensityatright
parahilar zone (Figure 1).
Figure 1: Chest x-ray shows a well-delineated mass (arrow) in
the right middle mediastinum.
A thorax CT revealed an anterior mediastinal necrotic
masssized10x11cmandmultiplelymphnodes(Figure
2).
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mass(M)containinghypodenseareascausedbynecrosis.Note
the right paratracheal and aorticopulmonary lymph nodes
(arrows).
We then performed a mediastinotomy and, based on the
histopathological findings, diagnosed this tumor as a
thymiccarcinoidtumor.Ultrasonographyoftheabdomen,
totalbonescintigraphy,andcranialcomputedtomography
were normal. We did not see any evidence of distant
metastasis.
During the sternotomy, we saw a brown, hard, calcified
concentrated mass with an irregular surface that com-
pletely filled the anterior mediastinum and was attached
to the medial side of both lungs, the pericardium and the
vena brachiocephalica sinistra. The tumor was carefully
excised together with the anterior pericardium and some
lung tissue. Mediastinal lymph node dissection was also
performed, followed by the appropriate closure of the
sternotomy.Therewerenocomplicationsinthepostoper-
ative period. The patient was discharged after recovery
on the 5th postoperative day.
The detailed histopathological findings confirmed the
diagnosis of a thymic carcinoid tumor (Figure 3).
Figure 3: The histopathological examination confirmed that
thelesionrepresentedathymiccarcinoid(Hematoxylin&Eosin
stain x 100).
During the follow–up, patient complained of diplopia. An
ophthalmologic examination revealed left 6th cranial
nerve palsy. A cranial MRI showed a mass lesion eroding
andprotrudingthroughthesellaturcicaandinvadingthe
cavernous sinus (Figure 4).
Figure 4: Gadolinium-enhanced T1-weighted MRI showed a
hyperintense, metastatic mass (m) in the suprasellar region.
The mass extended through the left cavernous sinus (white
arrow) and extends towards the back through the dorsum and
clivus (black arrow).
These findings suggested a cavernous sinus syndrome
caused by cavernous sinus metastasis. We then used
Cisplatin (100 mg/m2) and Etoposide (80 mg/m2) regi-
men(4cycles).Patientunderwentmediastinalandcranial
radiotherapy.Thelesiondisappearedcompletelyandthe
patient recovered without any further complications. He
was asymptomatic during his 18 months follow-up after
the operation.
Discussion
Thymic carcinoid tumors are rare neoplasms with a poor
prognosis, especially in the event of an extrathymic inva-
sion or lymph node metastases. They occur in all age
groups, but predominantly in men.
Thereisafrequentassociationwithendocrinedisorders.
First, there is an association with Cushing syndrome due
totheectopicadrenocorticotrophichormoneproduction,
which has been reported in 20% to 35% of all patients.
Second, Multiple Endocrine Neoplasia Type 1 has been
reported in 25% of all thymic carcinoids [3], [4]. Our pa-
tient had no associated hormonal hypersecretion.
Most patients present with symptoms of chest pain,
cough, and fatigue. Often, a routine chest x-ray has been
able to show the carcinoid tumor in asymptomatic pa-
tients [5].
Thymic carcinoids vary in size from less than 2 cm to
more than 10 cm in diameter. They are of soft consist-
ency,appeargrayish-whitetobrownishonthecutsurface,
and more than half of them display intraparenchymal
necrosis or hemorrhages. The tumors are usually well
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mediastinal fatty tissue, pleura, lung, pericardium, or
vena brachiocephalica sinistra are also sometimes af-
fected [6]. In our case, the mass measured 6 x 10 x 11
cmandhadinvadedthelungs,thepericardium,thevena
brachiocephalica sinistra and the aortic adventitia.
Chest x-rays, CTs, MRIs and PETS can be very helpful in
diagnosing this type of tumor.
The therapy of choice for thymic carcinoid tumors is sur-
gery. Resection of these tumors usually includes all of
the thymus and the perithymic fatty tissue. Lymph nodes
should routinely be dissected. If the tumor has invaded
the vena cava superior, the pulmonary vessels, or the
aorta or if the surgical resection is incomplete, the diag-
nosisispoor[7].Anaggressiveresectionmayincludethe
pericardium, adherent lung tissue, mediastinal nodes,
and occasionally a phrenic nerve. Complete surgical ex-
cision is absolutely necessary for a positive outcome.
Even after a resection, most patients develop distant
metastases. Local recurrence is also frequent, and the
disease-freeintervalisgenerallyshort.Nevertheless,the
intermediate-term survival rate is fairly good [8].
This tumor typically spreads by local invasion and metas-
tasizesmostcommonlytothelung,theliver,thekidneys,
the lymph nodes, and the bone and sometimes even to
the central nervous system [9], [10]. Extrathoracic
metastasis can be observed in 20% to 30% of all diag-
nosedpatients.Thecavernoussinusisanextremelyrare
metastasis site for a thymic carcinoid tumor. It may be
hematogenous.Inthiscase,acavernoussinussyndrome
mayoccur.Thecavernoussinussyndromemaybecaused
by a wide range of pathological processes such as a
trauma, a neoplasm, an intracavernous internal carotid
artery aneurysm or a metastatic disease. The lesions
within the cavernous sinus could simultaneously induce
abducensnervepalsy.Patientswiththissyndromeexperi-
encediplopia,ptosis,andfacialpainandnumbness[11],
[12]. We noted the cavernous sinus syndrome caused by
cavernous sinus metastasis in the postoperative 8
th
month. He complained of diplopia. The symptom was
treatedanddisappearedwithinafewdays.Weemphasize
that this is the first case caused by a metastasis from a
thymic carcinoid.
The role of adjuvant or neoadjuvant radiotherapy,
chemotherapy,orbothhasnotbeenadequatelyassessed
because of the low number of cases. Adjuvant therapy
may have mixed short-term results, although it had little
impact on long-term survival [3]. However, in our case,
adjuvantradiotherapyandchemotherapywereperformed
successfully during the postoperative period.
In conclusion, thymic carcinoid tumors have a poor
prognosis because of their high degree of malignancy,
earlymetastasis,anddelayeddiagnosis.Thus,treatment
of a patient with this tumor calls for prompt diagnosis,
surgical treatment, and optimal adjuvant therapy.
Moreover, these tumors can totally be removed together
with the pericardium with a low morbidity and mortality
risk without requiring excessive dissection when it is dif-
ficult to remove them due to excessive adhesion to the
surrounding tissue. In addition, if cranial symptoms such
asdiplopiaareobservedinpatientswiththymiccarcinoid,
the physicians should check for cavernous sinus metas-
tasis. If a cavernous sinus syndrome is diagnosed early,
treatment with radiotherapy and chemotherapy can
achieve very satisfactory early and late results.
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